SCHEMBL3413639

SCHEMBL3413639

O=C(Nc1c(=O)[nH]n2c(=O)c3ccccc3[nH]c12)c1cccc(Cl)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
PRMT5 O14744 1/20 0.44
KDM4E B2RXH2 1/20 0.44
GAA P10253 1/20 0.44
ABCC9 O60706 1/20 0.43
ABCC8 Q09428 1/20 0.43
KCNJ11 Q14654 1/20 0.43
KCNJ8 Q15842 1/20 0.43
KCNK3 O14649 1/20 0.43
KCNK9 Q9NPC2 1/20 0.43
MAPT P10636 2/20 0.42
TP53 P04637 1/20 0.42
BRD4 O60885 1/20 0.42
RXFP1 Q9HBX9 1/20 0.41
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
BRAF P15056 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3407406 0.89 BRD4 (0.46) MEN1KMT2ANPC1RAB9AKDM4E
SCHEMBL3407740 0.80 NPC1 (0.49) MEN1KMT2ANPC1RAB9AKDM4E
SCHEMBL3409988 0.78 MAPT (0.53) MEN1KMT2ANPC1KDM4EGAA
SCHEMBL2637478 0.74 HSP90AA1 (0.47) MEN1KMT2ANPC1RAB9AKCNK3
SCHEMBL3411281 0.70 EGFR (0.52) MEN1KMT2ANPC1RAB9ABRD4
SCHEMBL2637556 0.70 POLB (0.46) MEN1KMT2ANPC1RAB9AKDM4E
SCHEMBL16111189 0.69 POLB (0.55) MEN1KMT2AKDM4EGAAMAPT
SCHEMBL3408234 0.68 KDM4E (0.54) MEN1KMT2AKDM4EGAAMAPT
SCHEMBL3411555 0.68 ALDH1A1 (0.46) MEN1KMT2ANPC1RAB9AKDM4E
SCHEMBL3410873 0.67 ALDH1A1 (0.41) MEN1KMT2AKDM4EMAPTRXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2264035-A1 Glycine B antagonists Merz Pharma GmbH & Co. KGaA (DE) 2010-12-22 EP claimed
EP-2264035-A1 Glycine B antagonists Merz Pharma GmbH & Co. KGaA (DE) 2010-12-22 EP disclosed